---
id: "318"
slug: problem-of-managing-type-1-diabetes-without-ai-assistan
title: Problem of managing type 1 diabetes without AI assistance
status: enriched
source:
  name: manual
  url: "https://problemhunt.pro/en/health/bx6kjqfm21-problem-of-managing-type-1-diabetes-without-ai"
category: health
date: "2025-10-29"
tags: [Health, AI, Other]
country: Serbia
tech: [Next.js 14 (mobile-web), Python (FastAPI) backend, Postgres + TimescaleDB, OpenAI API, Dexcom / Libre CGM adapters, Apple Health / Google Fit, Hetzner (EU)]
---
# Problem of managing type 1 diabetes without AI assistance

> Auto-generated product brief. Review and refine before MVP scoping.

## Value Proposition

A Serbian T1 patient gets a daily pattern brief and a real-time glucose-trajectory alert in Serbian, with a structured summary they can hand to their endocrinologist at the next visit.

## Target Users

| Stakeholder | Why they care |
|---|---|
| Serbian T1 adult patient | Uses a CGM and a pump or MDI; wants pattern insight between endocrinologist visits. |
| Parent of a Serbian T1 child | Wants a real-time alert when glucose is heading toward hypo overnight. |
| Serbian endocrinologist | Wants a structured pattern summary per patient between visits. |

## Jobs To Be Done

1. **Functional job** — Pre-empt the glucose excursion before it happens, not after.
2. **Emotional job** — Stop the burnout of tracking everything manually and still missing the pattern.
3. **Social job** — Hand the endocrinologist a clean summary that justifies a therapy change, instead of 'I think my numbers are worse'.

## Success Metrics

- Time-in-range delta ≥ +5% over 90 days (median user).
- Daily active retention ≥ 50% after week 4.
- Hypo alert precision — ≥ 80% of alerts correspond to a true hypo within the predicted window.
- Endocrinologist NPS ≥ 50 from users who shared the structured summary.

## Pricing & Monetization

Free tier: 7-day CGM history, daily brief, no real-time alerts. Patient Pro (€9/month): full CGM history, real-time alerts, endocrinologist summary export. Family plan (€19/month for up to 3 patients): includes a parent's view for T1 children.

## Competitive Landscape

- Dexcom Clarity / Libre View — vendor dashboards; no meal/insulin correlation; no real-time alerts.
- Sugarmate / xDrip — strong real-time alerts but no pattern interpretation.
- Tidepool / Glooko — data aggregation, no AI pattern detection.

## Risks & Open Questions

- [ ] Medical-device classification risk — Mitigation: explicit 'educational, not medical advice' disclaimer; no automated insulin dosing; legal review before launch.
- [ ] CGM API drift — Dexcom and Abbott change contracts. Mitigation: per-vendor adapter isolation; nightly canary ping.
- [ ] Serbian-language medical copy accuracy — Mitigation: medically-reviewed copy; endocrinologist on retainer for first 90 days.

---

_Source:_ [manual](https://problemhunt.pro/en/health/bx6kjqfm21-problem-of-managing-type-1-diabetes-without-ai) · **Category:** health · **Tags:** Health, AI, Other
